BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 30463539)

  • 1. Pancreatic cancer: challenges and opportunities.
    Zhu H; Li T; Du Y; Li M
    BMC Med; 2018 Nov; 16(1):214. PubMed ID: 30463539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized therapy for pancreatic cancer: Do we need better targets, arrows, or both?
    O'Hayer KM; Brody JR
    Discov Med; 2016 Feb; 21(114):117-23. PubMed ID: 27011047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic Cancer: Progress and Challenges in a Rapidly Moving Field.
    Collisson EA; Olive KP
    Cancer Res; 2017 Mar; 77(5):1060-1062. PubMed ID: 28209609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of precision medicine in pancreatic cancer prevention and treatment].
    Wang CF
    Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):161-4. PubMed ID: 26988819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pancreatic Cancer in the Year 2018 - Room for Precision Medicine?].
    Simon O; Beyer G; Mahajan UM; Mayerle J
    Dtsch Med Wochenschr; 2018 Aug; 143(15):1109-1112. PubMed ID: 30060283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and molecular alterations in pancreatic cancer: implications for personalized medicine.
    Fang Y; Yao Q; Chen Z; Xiang J; William FE; Gibbs RA; Chen C
    Med Sci Monit; 2013 Oct; 19():916-26. PubMed ID: 24172537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes.
    McGuigan A; Kelly P; Turkington RC; Jones C; Coleman HG; McCain RS
    World J Gastroenterol; 2018 Nov; 24(43):4846-4861. PubMed ID: 30487695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Has Personalized Medicine for Pancreatic Cancer Arrived?
    Krepline A; Tsai S
    Adv Surg; 2019 Sep; 53():103-115. PubMed ID: 31327440
    [No Abstract]   [Full Text] [Related]  

  • 9. Pancreatic cancer: diagnosis and treatments.
    Li HY; Cui ZM; Chen J; Guo XZ; Li YY
    Tumour Biol; 2015 Mar; 36(3):1375-84. PubMed ID: 25680410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Diversity of Pancreatic Ductal Adenocarcinoma and Opportunities for Precision Medicine.
    Knudsen ES; O'Reilly EM; Brody JR; Witkiewicz AK
    Gastroenterology; 2016 Jan; 150(1):48-63. PubMed ID: 26385075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysis.
    Court CM; Ankeny JS; Hou S; Tseng HR; Tomlinson JS
    Expert Rev Mol Diagn; 2015; 15(11):1491-504. PubMed ID: 26390158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging inorganic nanomaterials for pancreatic cancer diagnosis and treatment.
    Yang F; Jin C; Subedi S; Lee CL; Wang Q; Jiang Y; Li J; Di Y; Fu D
    Cancer Treat Rev; 2012 Oct; 38(6):566-79. PubMed ID: 22655679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics and Personalized Medicine in Pancreatic Cancer.
    Hosseini Bereshneh A; Morshedi F; Hematyar M; Kaki A; Garshasbi M
    Acta Med Iran; 2017 Mar; 55(3):194-199. PubMed ID: 28282719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updated therapeutic outcome for patients with periampullary and pancreatic cancer related to recent translational research.
    Buanes TA
    World J Gastroenterol; 2016 Dec; 22(48):10502-10511. PubMed ID: 28082802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current diagnosis and treatment of pancreatic cancer in China.
    Guo X; Cui Z
    Pancreas; 2005 Jul; 31(1):13-22. PubMed ID: 15968242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for early pancreatic ductal adenocarcinoma: an urgent call!
    Lee MX; Saif MW
    JOP; 2009 Mar; 10(2):104-8. PubMed ID: 19287101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Practice and challenge of precision medicine for pancreatic cancer].
    Shi XH; Jin G
    Zhonghua Wai Ke Za Zhi; 2020 Jan; 58(1):37-41. PubMed ID: 31902168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic strategies in the search for novel pancreatic cancer biomarkers and drug targets: recent advances and clinical impact.
    Coleman O; Henry M; McVey G; Clynes M; Moriarty M; Meleady P
    Expert Rev Proteomics; 2016; 13(4):383-94. PubMed ID: 26985644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress of Exosomes in the Diagnosis and Treatment of Pancreatic Cancer.
    Wu H; Chen X; Ji J; Zhou R; Liu J; Ni W; Qu L; Ni H; Ni R; Bao B; Xiao M
    Genet Test Mol Biomarkers; 2019 Mar; 23(3):215-222. PubMed ID: 30793953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Pancreatic Cancer: Targets for Early Detection and Treatment.
    Lerch MM; Mayerle J; Mahajan U; Sendler M; Weiss FU; Aghdassi A; Moskwa P; Simon P
    Dig Dis; 2016; 34(5):525-31. PubMed ID: 27332960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.